Genuinely doesnt sound like they need cash mate. It's all sounding on track for a big turnaround to me, by end of calendar year we should have maybe 10,000 units across the states generating clinical revenue and an e-commerce platform on-line and ready for future OTC revenue, which recent trial data has validated so the clearance pathway is more orderly.
